Literature DB >> 17596315

An adenovirus vector-mediated reverse genetics system for influenza A virus generation.

Makoto Ozawa1, Hideo Goto, Taisuke Horimoto, Yoshihiro Kawaoka.   

Abstract

Plasmid-based reverse genetics systems allow the generation of influenza A virus entirely from cloned cDNA. However, since the efficiency of virus generation is dependent on the plasmid transfection efficiency of cells, virus generation is difficult in cells approved for vaccine production that have low transfection efficiencies (e.g., Vero cells). Here we established an alternative reverse genetics system for influenza virus generation by using an adenovirus vector (AdV) which achieves highly efficient gene transfer independent of cell transfection efficiency. This AdV-mediated reverse genetics system will be useful for generating vaccine seed strains and for basic influenza virus studies.

Entities:  

Mesh:

Year:  2007        PMID: 17596315      PMCID: PMC1951417          DOI: 10.1128/JVI.01042-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Plasmid-driven formation of influenza virus-like particles.

Authors:  G Neumann; T Watanabe; Y Kawaoka
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

Authors:  Gabriele Neumann; Michael A Whitt; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

Review 3.  Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA.

Authors:  G Neumann; Y Kawaoka
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

4.  The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

Authors:  Taisuke Horimoto; Ayato Takada; Ken Fujii; Hideo Goto; Masato Hatta; Shinji Watanabe; Kiyoko Iwatsuki-Horimoto; Mutsumi Ito; Yuko Tagawa-Sakai; Shinya Yamada; Hirotoshi Ito; Toshihiro Ito; Masaki Imai; Shigeyuki Itamura; Takato Odagiri; Masato Tashiro; Wilina Lim; Yi Guan; Malik Peiris; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2005-07-21       Impact factor: 3.641

5.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  Generation of influenza A virus from cloned cDNAs--historical perspective and outlook for the new millenium.

Authors:  Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Rev Med Virol       Date:  2002 Jan-Feb       Impact factor: 6.989

7.  Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.

Authors:  H Goto; R C Bethell; Y Kawaoka
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

Review 8.  From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

Authors:  John M Wood; James S Robertson
Journal:  Nat Rev Microbiol       Date:  2004-10       Impact factor: 60.633

9.  Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

Authors:  Kanta Subbarao; Hualan Chen; David Swayne; Louise Mingay; Ervin Fodor; George Brownlee; Xiyan Xu; Xiuhua Lu; Jacqueline Katz; Nancy Cox; Yumiko Matsuoka
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

10.  Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Authors:  R J Webby; D R Perez; J S Coleman; Y Guan; J H Knight; E A Govorkova; L R McClain-Moss; J S Peiris; J E Rehg; E I Tuomanen; R G Webster
Journal:  Lancet       Date:  2004-04-03       Impact factor: 79.321

View more
  7 in total

1.  Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion.

Authors:  Shin Murakami; Taisuke Horimoto; Mutsumi Ito; Ryo Takano; Hiroaki Katsura; Masayuki Shimojima; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice.

Authors:  Julia Steitz; Peter G Barlow; Jaber Hossain; Eun Kim; Kaori Okada; Tom Kenniston; Sheri Rea; Ruben O Donis; Andrea Gambotto
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

3.  Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production.

Authors:  Shin Murakami; Taisuke Horimoto; Shinya Yamada; Satoshi Kakugawa; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

4.  Developing vaccines to combat pandemic influenza.

Authors:  James S Robertson; Othmar G Engelhardt
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818

5.  Adenovirus vector-mediated assay system for hepatitis C virus replication.

Authors:  Takeshi Yoshida; Masuo Kondoh; Manabu Ojima; Hiroyuki Mizuguchi; Yoshiaki Yamagishi; Naoya Sakamoto; Kiyohito Yagi
Journal:  Nucleic Acids Res       Date:  2011-02-08       Impact factor: 16.971

Review 6.  Many ways to make an influenza virus--review of influenza virus reverse genetics methods.

Authors:  Othmar G Engelhardt
Journal:  Influenza Other Respir Viruses       Date:  2012-06-19       Impact factor: 4.380

7.  A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.

Authors:  Makoto Ozawa; Masayuki Shimojima; Hideo Goto; Shinji Watanabe; Yasuko Hatta; Maki Kiso; Yousuke Furuta; Taisuke Horimoto; Noel R Peters; F Michael Hoffmann; Yoshihiro Kawaoka
Journal:  Sci Rep       Date:  2013-01-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.